ライフサイエンスコーパス: bioprostheses

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 agement of structural degeneration of aortic bioprostheses.

2 n degenerate in a manner similar to surgical bioprostheses.

3 -TAVR with Edwards SAPIEN balloon-expandable bioprostheses.

4 types, including transcatheter and surgical bioprostheses.

5 rmacologic treatments and developing durable bioprostheses.

6 valve deterioration (SVD) is a major flaw of bioprostheses.

7 agulation in patients receiving aortic valve bioprostheses.

8 structural deterioration and reoperation of bioprostheses.

9 eses are hemodynamically superior to stented bioprostheses.

10 hanical valves and the limited durability of bioprostheses.

11 are superior with newer compared with older bioprostheses.

12 rtant drawback of surgical and transcatheter bioprostheses.

13 both transcatheter and surgical aortic valve bioprostheses.

14 a viable option for treatment of failing TV bioprostheses.

15 All had tricuspid valve replacement (159 bioprostheses, 36 mechanical), and 157 underwent a pulmo

16 The lack of durable bioprostheses and pharmacologic therapies remain central

17 Survival was lower among patients with small bioprostheses and those with predominant surgical valve

18 Both stented and stentless bioprostheses are associated with excellent clinical and

19 It is presumed that stentless aortic bioprostheses are hemodynamically superior to stented bi

20 ts >/=65 years of age receiving aortic valve bioprostheses at 797 hospitals within the Society of Tho

21 symptomatic degeneration of surgical aortic bioprostheses at high risk (>/=50% major morbidity or mo

22 series who required reoperation had received bioprostheses at the first operation.

23 late valve degeneration (VD) associated with bioprostheses (BPs).

24 long-term durability of current pericardial bioprostheses compares with the traditional porcine biop

25 In an ovine model, tubular SIS-ECM TV bioprostheses demonstrate "growth" and a cell-matrix str

26 vidence of accelerated deterioration of such bioprostheses during pregnancy.

27 (Registry of Aortic Valve Bioprostheses Established by Catheter [FRANCE TAVI]; NCT

28 At present, bioprostheses for the diseased aortic valve include sten

29 dysfunctional surgical tricuspid valve (TV) bioprostheses has been described in small reports.

30 Patients receiving aortic valve bioprostheses have an elevated early risk of thromboembo

31 ess the safety of AVR with other pericardial bioprostheses in children and the youngest adults.

32 s will increasingly present with degenerated bioprostheses in the next few years.

33 nt (AVR) with current-generation pericardial bioprostheses in young patients is limited.

34 The use of bioprostheses in young women anticipating future pregnan

35 he presence of thrombi, and in patients with bioprostheses, is discussed.

36 ients with ventricular impairment, stentless bioprostheses may allow for greater improvement in left

37 Structural deterioration of bioprostheses occurred in 64 patients (2.4%).

38 With new bioprostheses on the horizon, there is renewed interest

39 comes in high-risk patients with degenerated bioprostheses or failed annuloplasty rings, but mitral V

40 ts after aortic valve replacement (AVR) with bioprostheses or mechanical prostheses.

41 the primary biomaterial used in heart valve bioprostheses, recipient graft-specific immune responses

42 araldehyde cross-linked porcine aortic valve bioprostheses represents a highly efficacious and mechan

43 ant risk of reoperation following the use of bioprostheses suggests that mechanical valves may be und

44 Among 397 consecutive cases of explanted bioprostheses, there were 46 cases of BPVT (11.6%; aorti

45 a considerable increase in the use of aortic bioprostheses (vs. mechanical prostheses) for treating a

46 Structural deterioration of aortic bioprostheses was rare.

47 Bioprostheses were associated with a higher long-term ri

48 Stentless aortic bioprostheses were designed to provide enhanced hemodyna

49 Bioprostheses were used in 145 (69%) and mechanical pros

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。